Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Preparedness News Releases

  
September 20, 2019: HHS Provides Expertise, $14 Million to Advance Development of Investigational Ebola Treatment
September 16, 2019: HHS expands network of innovation accelerators to transform U.S. health security
September 3, 2019: HHS Purchases Smallpox Vaccine to Enhance Biodefense Preparedness
September 3, 2019: OCR Issues Guidance to Help Ensure Equal Access to Emergency Services and the Appropriate Sharing of Medical Information during Hurricane Dorian
September 2, 2019: HHS Secretary Azar Declares Public Health Emergencies for States of Georgia and South Carolina Due to Hurricane Dorian
August 30, 2019: HHS Secretary Azar Declares Public Health Emergency for State of Florida Due to Hurricane Dorian
August 28, 2019: HHS Secretary Azar Declares Public Health Emergency for Puerto Rico Due to Hurricane Dorian
August 21, 2019: HHS Funds an Additional Year of Ebola Vaccine Manufacturing
July 22, 2019: First medical product cleared in U.S. for use on certain injuries caused by sulfur mustard
July 22, 2019: HHS, DoD, VenatoRx Pharmaceuticals to co-develop novel antibiotic to treat drug-resistant infections
July 18, 2019: HHS sponsors development of portable, user-friendly burn imaging device
June 25, 2019: New law strengthens U.S. efforts to prepare, respond and recover from disasters
May 29, 2019: HHS Seeks to Expand its Network Innovation Accelerators into More States
March 5, 2019: HHS’ BARDA funds its first Marburg virus vaccine development
February 21, 2019: New HHS-Sponsored Research Provides New Tool and Updated Guidance on Mass Chemical Decontamination
December 28, 2018: HHS, in Partnership with Industry, Releases Voluntary Cybersecurity Practices for the Health Industry
October 10, 2018: HHS expands corporate partnership to protect against health security threats
October 2, 2018: HHS seeks to repurpose burn dressings for radiation emergencies
October 1, 2018: HHS, Genentech join forces on medicines to combat influenza, other health security threats
September 27, 2018: HHS Selects Pilot Projects to Demonstrate Better Approach to Disaster Medical Care
September 25, 2018: HHS sponsors new formulation of world’s first approved smallpox drug
September 25, 2018: HHS partners to develop faster tests to identify bacterial infections
September 24, 2018: HHS enlists MediWound to develop treatment for sulfur mustard injury
24 de septiembre de 2018: Un año después: Los esfuerzos a largo plazo en curso en Puerto Rico
24 de septiembre de 2018: Un año después de María: La lucha emocional es real y la ayuda aún está disponible
September 24, 2018: One Year Later: Long-Term Recovery Efforts Underway in Puerto Rico
September 24, 2018: One Year After Maria: The Emotional Struggle is Real and Help is Still Available
September 20, 2018: HHS Sponsors Development of Intranasal Form of Long-acting Opioid Overdose Drug
September 18, 2018: National Biodefense Strategy: Protect the Nation Against all Biological Threats
July 16, 2018: HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
July 13, 2018: Statement by Rick Bright, PhD, Director of ASPR’s Biomedical Advanced Research and Development Authority on the recent FDA approval of TPOXX® as a treatment for smallpox
June 25, 2018: HHS enlists AktiVax to develop improved auto-injector for nerve agent antidotes
June 5, 2018: Seattle-Bellevue company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Raleigh-Durham company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Greater Boston company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Los Angeles company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018:New Orleans company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: New York Tristate Area company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Houston company selected to accelerate innovation for U.S. health security, daily medical care
June 5, 2018: Philadelphia company selected to accelerate innovation for U.S. health security, daily medical care
April 27, 2018: HHS Partners to develop new treatment for seizures caused by nerve agents
April 23, 2018: HHS purchases anthrax antitoxin for Strategic National Stockpile
March 29, 2018: FDA approves Leukine for Acute Radiation Syndrome
October 6, 2017: HHS pursues therapeutic for radiation injury affecting blood platelets
October 6, 2017: HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria
October 3, 2017: HHS sponsors development of two tests for radiation exposure
October 3, 2017: HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases
October 2, 2017: HHS pursues reusable respirator to better protect medical providers during pandemics
September 29, 2017: HHS accelerates development of first Ebola vaccines and drugs
September 28, 2017: HHS boosts biodefense preparedness with smallpox vaccine for special populations
1 - 50Next
​​
​​
​​​

Stay Up To Date with PHE.gov

 

Watch, Listen, Subscribe

 
Facebook Exit Icon Twitter Exit Icon YouTube Exit Icon
Email via GovDelivery Exit Icon LinkedIn Exit Icon

  • This page last reviewed: May 08, 2019